Abstract:Background/Aims: Histone deacetylases (HDACs) play a critical role in the regulation of gene transcription, cardiac development, and diseases. The aim of this study was to investigate whether the inhibition of HDACs improves cardiac remodeling and its underlying mechanisms in a mouse myocardial infarction (MI) model. Methods: The HDAC inhibitor trichostatin A (TSA, 0.1 mg/kg/day) was administered via daily intraperitoneal injections for 8 consecutive weeks after MI in C57/BL mice. Echocardiography and tissue histopathology were used to assess cardiac function. Cultured neonatal rat cardiac fibroblasts (NRCFs) were subjected to simulated hypoxia in vitro. Autophagic flux was measured using the tandem fluorescent mCherry-GFP-LC3 assay. Western blot was used to detect autophagic biomarkers. Results: After 8 weeks, the inhibition of HDACs in vivo resulted in improved cardiac remodeling and hence better ventricular function. MI was associated with increased LC3-II expression and the accumulation of autophagy adaptor protein p62, indicating impaired autophagic flux, which was reversed by TSA treatment. Cultured NRCFs exhibited increased cell death after simulated hypoxia in vitro. Increased cell death was associated with markedly increased numbers of autophagosomes but not autolysosomes, as assessed by punctate dual fluorescent mCherry-green fluorescent protein tandem-tagged light chain-3 expression, indicating that hypoxia resulted in impaired autophagic flux. Importantly, TSA treatment reversed hypoxia-induced impaired autophagic flux and led to a 40% decrease in cell death. This was accompanied by improved mitochondrial membrane potential. The beneficial effects of TSA therapy were abolished by RNAi intervention targeting LAMP2; likewise, in vivo delivery of chloroquine abolished the TSA-mediated cardioprotective effects. Conclusion: Our results provide evidence that the HDAC inhibitor TSA prevents cardiac remodeling after MI and is dependent on restoring autophagosome processing of cardiac fibroblasts. (C) 2018 The Author(s) Published by S. Karger AG, Basel

Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation

Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury

Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts.

Selective Inhibition of Class IIa Histone Deacetylases Alleviates Renal Fibrosis

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.

Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury

HDAC6 Inhibition Alleviates Ischemia- and Cisplatin-Induced Acute Kidney Injury by Promoting Autophagy

Treatment of chronic kidney diseases with histone deacetylase inhibitors.

Inhibition Of Class I Hdacs Attenuates Renal Interstitial Fibrosis In A Murine Model

HDAC2 Targeting Stabilizes the CoREST Complex in Renal Tubular Cells and Protects Against Renal Ischemia/reperfusion Injury

Inhibition of HDAC6 with CAY10603 Alleviates Acute and Chronic Kidney Injury by Suppressing the ATF6 Branch of UPR

Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.

[Histone deacetylases and acute kidney injury].

Inhibition of ACSF2 protects against renal ischemia/reperfusion injury via mediating mitophagy in proximal tubular cells

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Degradation of histone deacetylase 6 alleviates ROS-mediated apoptosis in renal ischemia-reperfusion injury

Histone Deacetylases Take Center Stage on Regulation of Podocyte Function

Histone Deacetylase Inhibitors Protect Against Cisplatin-Induced Acute Kidney Injury by Activating Autophagy in Proximal Tubular Cells.

Pharmacological and genetic inhibition of HDAC4 alleviates renal injury and fibrosis in mice

Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression